Amgen Inc. Business Finance Contracts & Agreements

87 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amended and Restated Credit Agreement, dated as of March 9, 2023, among Amgen Inc., the Banks therein named, Citibank, N.A., as Administrative Agent, and JPMorgan Chase...
Credit Agreements
Amgen Inc.
Biotechnology
DE
2023
Officers Certificate of the Company, dated as of March 2, 2023, including forms of the Companys 5.250% Senior Notes due 2025, 5.507% Senior Notes due 2026, 5.150% Senior Notes due...
Note Agreements
Amgen Inc.
Biotechnology
NY
2023
Underwriting Agreement, dated February 15, 2023, by and among the Company and Citigroup Global Markets Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC and Mizuho Securities...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2023
Amendment No. 3 to Share Purchase Agreement, dated January 30, 2023, by and among BeiGene, Ltd. and Amgen Inc
Share Agreements
Amgen Inc.
Biotechnology
2023
Term Loan Credit Agreement, dated as of December 22, 2022, by and among Amgen Inc., Citibank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, Citibank,...
Loan Agreements
Amgen Inc.
Biotechnology
DE
2022
Bridge Credit Agreement, dated as of December 12, 2022, by and among Amgen Inc., Citibank, N.A., as administrative agent, Bank of America, N.A., as syndication agent, Citibank,...
Credit Agreements
Amgen Inc.
Biotechnology
DE
2022
Officers Certificate of the Company, dated as of August 18, 2022, including forms of the Companys 4.050% Senior Notes due 2029, 4.200% Senior Notes due 2033 and 4.875% Senior...
Note Agreements
Amgen Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated August 15, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC and Deutsche Bank...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2022
Officers Certificate of the Company, dated as of February 22, 2022, including forms of the Companys 3.000% Senior Notes due 2029, 3.350% Senior Notes due 2032, 4.200% Senior Notes...
Note Agreements
Amgen Inc.
Biotechnology
NY
2022
Underwriting Agreement, dated February 17, 2022, by and among the Company and BofA Securities, Inc., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Goldman Sachs &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2022
Officers Certificate of the Company, dated as of August 9, 2021, including forms of the Companys 1.650% Senior Notes due 2028, 2.000% Senior Notes due 2032, 2.800% Senior Notes...
Note Agreements
Amgen Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated August 5, 2021, by and among the Company and Citigroup Global Markets Inc., Morgan Stanley & Co. LLC, Barclays Capital Inc. and Goldman Sachs & Co....
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2021
Restated Amendment No. 2 to Share Purchase Agreement, dated September 24, 2020, by and among BeiGene, Ltd. and Amgen Inc
Share Agreements
Amgen Inc.
Biotechnology
NY
2020
Registration Rights Agreement, dated as of August 17, 2020, by and among the Company, BofA Securities, Inc. and J.P. Morgan Securities LLC, as lead dealer managers, and BNP...
Registration Rights Agreements
Amgen Inc.
Biotechnology
NY
2020
Officers Certificate of Amgen Inc., dated as of August 17, 2020, including forms of the Companys 2.770% Senior Notes due 2053
Note Agreements
Amgen Inc.
Biotechnology
NY
2020
Officers Certificate of the Company, dated as of May 6, 2020, including the form of the Companys 2.300% Senior Notes due 2031
Note Agreements
Amgen Inc.
Biotechnology
NY
2020
Underwriting Agreement, dated as of May 4, 2020, by and among the Company and BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Morgan Stanley &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Amendment No. 2 to Share Purchase Agreement, dated March 17, 2020, by and among BeiGene, Ltd. and Amgen Inc
Share Agreements
Amgen Inc.
Biotechnology
NY
2020
Officers Certificate of the Company, dated as of February 21, 2020, including forms of the Companys 1.900% Senior Notes due 2025, 2.200% Senior Notes due 2027, 2.450% Senior Notes...
Note Agreements
Amgen Inc.
Biotechnology
NY
2020
Underwriting Agreement, dated February 18, 2020, by and among the Company and Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Barclays Capital Inc. and Morgan Stanley &...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2020
Guarantee, dated as of October 31, 2019, made by and among BeiGene, Ltd. and Amgen Inc
Guarantee Agreements
Amgen Inc.
Biotechnology
2020
Amendment No. 2 to the Asset Purchase Agreement, dated October 17, 2019, by and between Amgen Inc. and Celgene Corporation
Purchase Agreements
Amgen Inc.
Biotechnology
2020
Second Amended and Restated Credit Agreement, dated as of December 12, 2019, among Amgen Inc., the Banks therein named, Citibank, N.A., as Administrative Agent, and JPMorgan Chase...
Credit Agreements
Amgen Inc.
Biotechnology
DE
2019
Amendment No. 1 to the Asset Purchase Agreement, dated August 25, 2019, by and between Amgen Inc. and Celgene Corporation
Purchase Agreements
Amgen Inc.
Biotechnology
2019
Asset Purchase Agreement, dated August 25, 2019, by and between Amgen Inc. and Celgene Corporation
Purchase Agreements
Amgen Inc.
Biotechnology
NY
2019
Irrevocable Guarantee, dated August 25, 2019, by and between Amgen Inc. and Bristol-Myers Squibb Company
Guarantee Agreements
Amgen Inc.
Biotechnology
DE
2019
Amendment No. 1 to the Credit Agreement, dated March 9, 2018, among Amgen Inc., the Banks therein named, and Citibank, N.A., as administrative agent
Credit Agreements
Amgen Inc.
Biotechnology
VA
2018
Officers Certificate of the Company, dated as of November 2, 2017, including the form of the Companys 3.200% Senior Notes due 2027
Note Agreements
Amgen Inc.
Biotechnology
NY
2017
Underwriting Agreement, dated October 31, 2017, by and among the Company and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BNP Paribas Securities Corp., as...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2017
AMGEN INC. $300,000,000SENIOR FLOATING RATE NOTES DUE 2019 $300,000,000 SENIOR FLOATING RATE NOTES DUE 2020 $700,000,000 1.900% SENIOR NOTES DUE 2019 $700,000,000 2.200% SENIOR...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2017
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Note Agreements
Amgen Inc.
Biotechnology
2017
AMGEN INC. $750,000,0001.850% SENIOR NOTES DUE 2021 $750,000,000 2.250% SENIOR NOTES DUE 2023 $1,250,000,000 2.600% SENIOR NOTES DUE 2026 $1,000,000,000 4.400% SENIOR NOTES DUE...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2016
REGISTRATION RIGHTS AGREEMENT among AMGEN INC. and CREDIT SUISSE SECURITIES(USA) LLC J.P. MORGAN SECURITIES LLC CITIGROUP GLOBAL MARKETS INC. and MIZUHO SECURITIES USA INC. each...
Credit Agreements
Amgen Inc.
Biotechnology
NY
2016
AMGENINC. 1,250,000,000 1.250% SENIOR NOTES DUE 2022 750,000,000 2.000% SENIOR NOTES DUE 2026 Underwriting Agreement
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2016
AMGENINC. $750,000,000 2.125% SENIOR NOTES DUE 2020 $500,000,000 2.700% SENIOR NOTES DUE 2022 $1,000,000,000 3.125% SENIOR NOTES DUE 2025 $1,250,000,000 4.400% SENIOR NOTES DUE...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2015
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange...
Exchange Agreements
Amgen Inc.
Biotechnology
NY
2015
AMENDED ANDRESTATED CREDIT AGREEMENT Dated as of July 30, 2014 among Amgen Inc., The Borrowing Subsidiaries Herein Named, The Banks Herein Named, Citibank, N.A., asAdministrative...
Credit Agreements
Amgen Inc.
Biotechnology
DE
2014
AMGEN INC. INDENTURE Dated as of May 22, 2014 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee TABLE OF CONTENTS
Indenture Agreements
Amgen Inc.
Biotechnology
NY
2014
AMGENINC. $850,000,000 1.250% SENIOR NOTES DUE 2017 $1,400,000,000 2.200% SENIOR NOTES DUE 2019 $1,400,000,000 3.625% SENIOR NOTES DUE 2024 $600,000,000 SENIOR FLOATING RATE NOTES...
Underwriting Agreements
Amgen Inc.
Biotechnology
NY
2014
AMENDMENT NO. 14 TO THE SHAREHOLDERS AGREEMENT OF KIRIN-AMGEN, INC.
Shareholders Agreements
Amgen Inc.
Biotechnology
CA
2014